Bridgeway Capital Management, LLC Aligos Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.87 - $2.11 $17,400 - $42,200	-20,000 Reduced 17.86%	92,000 $80,000
Q4 2022 Feb 14, 2023	BUY	$0.89 - $28.0 $29,370 - $924,000	33,000 Added 41.77%	112,000 $106,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.5 $23,320 - $605,000	22,000 Added 38.6%	79,000 $87,000
Q2 2022 Aug 15, 2022	BUY	$1.04 - $2.14 $59,280 - $121,980	57,000 New	57,000 $69,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.